Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer
AbstractGenome-wide DNA hypomethylation is associated with a worse prognosis in early-stage colorectal cancer. To measure genome-wide DNA methylation levels, long interspersed nucleotide element (LINE-1) repeats are used as a surrogate marker. Cohort studies on the clinical impact of genome-wide DNA methylation level in patients with only early-stage colon cancer, are currently lacking. This study aimed to investigate the prognostic value of LINE-1 methylation in a stage II colon cancer cohort (n = 164). Manual needle microdissection of tumor areas was performed on formalin-fixed paraffin-embedded tumor tissue sections followed by DNA extraction. Bisulfite converted DNA was used to assess tumor LINE-1 methylation level by qPCR. Patients with LINE-1 hypomethylated tumors had a significantly worse overall survival compared to patients with a higher level of LINE-1 tumor DNA methylation (HR 1.68, 95% CI 1.03–2.75; p = 0.04). This effect was more prominent in patients aged over 65 years (HR 2.00, 95% CI 1.13–3.52; p = 0.02), although the test for age interaction was not significant. No significant effect on recurrence-free survival was observed. Based on these results, tumor LINE-1 hypomethylation is associated with a worse overall survival in stage II colon cancer. Whether the origin of this causation is cancer-specific or age-related can be debated. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 646 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Swets, M.; Zaalberg, A.; Boot, A.; van Wezel, T.; Frouws, M.A.; Bastiaannet, E.; Gelderblom, H.; van de Velde, C.J.H.; Kuppen, P.J.K. Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer. Int. J. Mol. Sci. 2017, 18, 36.
Swets M, Zaalberg A, Boot A, van Wezel T, Frouws MA, Bastiaannet E, Gelderblom H, van de Velde CJH, Kuppen PJK. Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer. International Journal of Molecular Sciences. 2017; 18(1):36.Chicago/Turabian Style
Swets, Marloes; Zaalberg, Anniek; Boot, Arnoud; van Wezel, Tom; Frouws, Martine A.; Bastiaannet, Esther; Gelderblom, Hans; van de Velde, Cornelis J.H.; Kuppen, Peter J.K. 2017. "Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer." Int. J. Mol. Sci. 18, no. 1: 36.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.